Operating Lease, Right-of-Use Asset of Avalo Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Avalo Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Avalo Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $402,000, a 65% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Avalo Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $402,000 -$737,000 -65% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $487,000 -$724,000 -60% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $615,000 -$665,000 -52% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $741,000 -$588,000 -44% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $1,139,000 -$254,000 -18% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,211,000 -$246,000 -17% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $1,280,000 -$402,000 -24% 31 Mar 2024 10-Q/A 11 Jul 2024 2024 Q1
Q4 2023 $1,329,000 -$421,000 -24% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $1,393,000 -$420,000 -23% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,457,000 -$420,000 -22% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $1,682,000 -$258,000 -13% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $1,750,000 -$251,000 -13% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $1,813,000 +$1,115,000 +160% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $1,877,000 +$1,104,000 +143% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $1,940,000 +$1,094,000 +129% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $2,001,000 +$1,083,000 +118% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $698,000 -$285,411 -29% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $773,000 -$283,441 -27% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 $846,000 +$135,770 +19% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $918,000 +$199,374 +28% 31 Dec 2020 10-K 02 Mar 2022 2021 FY
Q3 2020 $983,411 +$264,298 +37% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $1,056,441 +$328,303 +45% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $710,230 -$27,428 -3.7% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $718,626 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q3 2019 $719,113 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $728,138 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $737,658 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.